Biotech

All Articles

FDA areas Kezar lupus trial in hold complying with 4 individual fatalities

.The FDA has actually placed Kezar Lifestyle Sciences' lupus test on hold after the biotech flagged ...

Phase 3 Academic Stone test reaches SMA objective, sending stock up 200%

.A phase 3 trial of Scholar Rock's spine muscle degeneration (SMA) applicant has actually reached it...

CAMP 4 is most recent to eye IPO, while Upstream spells out $182M strategy

.RNA biotech CAMP4 Therapeutics has actually marked out plans for a $67 thousand IPO, along with inf...

Galecto purchases leukemia medication, falls bone tissue cancer cells possession in pivot

.A year after the failing of an idiopathic pulmonary fibrosis applicant sent out Galecto on a search...

Judo tosses down $100M to knock out renal condition

.Taking the mat is actually Judo Bio, an ambitious biotech equipped with $100 thousand to cultivate ...

AstraZeneca spends CSPC $100M for preclinical heart disease medication

.AstraZeneca has actually paid off CSPC Pharmaceutical Group $one hundred thousand for a preclinical...

Zephyrm seeks Hong Kong IPO to fund stage 3 cell treatment trials

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, filing (PDF) for an IPO ...

Frazier Lifestyle Sciences gathers $630M for little, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced a better $630 million for its own fund focused on li...

GigaGen amasses around $135M BARDA bucks to beat botox

.Antibody fan GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its technicia...

GPCR organization Septerna files for IPO on durability of preclinical information

.Septerna is about to learn just how a biotech without "any sort of meaningful medical information" ...